The DOI matches its Crossref record; 252 of the 252 references it cites were found in a registry or an index.
The evolution of SARS-CoV-2
Open accessAbstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of deaths and substantial morbidity worldwide. Intense scientific effort to understand the biology of SARS-CoV-2 has resulted in daunting numbers of genomic sequences. We witnessed evolutionary events that could mostly be inferred indirectly before, such as the emergence of variants with distinct phenotypes, for example transmissibility, severity and immune evasion. This Review explores the mechanisms that generate genetic variation in SARS-CoV-2, underlying the within-host and population-level processes that underpin these events. We examine the selective forces that likely drove the evolution of higher transmissibility and, in some cases, higher severity during the first year of the pandemic and the role of antigenic evolution during the second and third years, together with the implications of immune escape and reinfections, and the increasing evidence for and potential relevance of recombination. In order to understand how major lineages, such as variants of concern (VOCs), are generated, we contrast the evidence for the chronic infection model underlying the emergence of VOCs with the possibility of an animal reservoir playing a role in SARS-CoV-2 evolution, and conclude that the former is more likely. We evaluate uncertainties and outline scenarios for the possible future evolutionary trajectories of SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The higher end of the ranges, with evolutionary rates up to 8 × 10 -3 substitutions per site per year, emphasises the potential for SARS-CoV-1 and similar coronaviruses to evolve rapidly, possibly even quicker than SARS-CoV-2.126”
From Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review (2025) · cites this paper as [126]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
EVOLUTION IN MENDELIAN POPULATIONS
Wright, S. (1931) · Genetics · doi:10.1093/genetics/16.2.97 · Cited by 9,237
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,729
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661
SARS-CoV-2 variants, spike mutations and immune escape
Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00573-0 · Cited by 3,528
Nextstrain: real-time tracking of pathogen evolutionPreprint
Hadfield, J., Megill, C., Bell, S. M., et al. (2017) · bioRxiv · doi:10.1101/224048 · Cited by 3,172
Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154
Cited by
Sorted by citations
Items 601–700 of 998
Quantum-Like Approaches Unveil the Intrinsic Limits of Predictability in Compartmental Models
Rojas-Venegas, J. A., Gallarta-Sáenz, P., Hurtado-Heredia, R., Gómez‐Gardeñes, J., & Soriano‐Paños, D. (2024) · Entropy · doi:10.3390/e26100888 · Cited by 2
In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants
Sharma, S., Roy, D., & Cherian, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-75658-w · Cited by 3
Goens, M. M., Howard, E. L., Warner, B. M., Susta, L., & Wootton, S. K. (2024) · Viruses · doi:10.3390/v16111794 · Cited by 2
Salim, H., Pont, L., Giménez, E., Poolsup, S., Berezovski, M. V., & Benavente, F. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.112505 · Cited by 2
Coronaviruses: Pandemic SARS-CoV-2
Cowling, B. J., & Wong, S. (2024) · Springer eBooks · doi:10.1007/978-1-4939-9544-8_68-1 · Cited by 2
Calderón-Pérez, B., Núñez-Muñoz, L. A., Trejo-Ayala, L. L., Rosales-García, V. H., Chávez-Álvarez, B. E., Vargas-Hernández, B. Y., Ramírez-Pool, J. A., Ruíz‐Medrano, R., & Xoconostle‐Cázares, B. (2024) · Virology · doi:10.1016/j.virol.2024.110380 · Cited by 2
Marine Origin vs. Synthesized Compounds: In Silico Screening for a Potential Drug Against SARS-CoV-2
Osmanović, A., Salihović, M., Veljović, E., Hindija, L., Pazalja, M., Malenica, M., Selmanagić, A., & Špirtović‐Halilović, S. (2024) · Scientia Pharmaceutica · doi:10.3390/scipharm93010002 · Cited by 2
Ali, D. W., Bartlett, M. L., Heger, C. D., Ramirez, F., Johnson, L., Schully, K. L., Laing, E. D., Wang, W., Weiss, C. D., Goguet, E., et al. (2024) · npj Viruses · doi:10.1038/s44298-024-00083-9 · Cited by 3
Santos, J. A. A., & Duay, S. S. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107387 · Cited by 2
Nawa, H., & Murakami, M. (2025) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12520 · Cited by 2
COVID-19: Lessons Learned from Molecular and Clinical Research
Rizzi, M., & Sainaghi, P. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020616 · Cited by 2
Scott, A., Puzniak, L., Murphy, M. V., Benjumea, D., Rava, A., Benigno, M., Allen, K. E., Stanford, R. H., Manuel, F., Chambers, R. B., et al. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2442515 · Cited by 2
Göbel, C. H., Heinze, A., Heinze‐Kuhn, K., Karstedt, S. C., Morscheck, M., Tashiro, L., Cirkel, A., Hamid, Q. A., Halwani, R., Temsah, M.-H. A., et al. (2025) · Vaccines · doi:10.3390/vaccines13020113 · Cited by 2
Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
Cavalli, M., Campoli, G., Anselmo, A., Brandi, R., Fortunato, A., Spirito, M. D., Monte, A., Lipari, M., Bortone, M., Fain, V. V., et al. (2025) · Scientific Reports · doi:10.1038/s41598-024-84952-6 · Cited by 2
SGV-caller: SARS-CoV-2 genome variation caller
Wu, J., Kryukov, K. A., Takeuchi, J. S., & Nakagawa, S. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42613 · Cited by 2
Benlarbi, M., Kenfack, D.-D., Dionne, K., Côté-Chenette, M., Beaudoin-Bussières, G., Bélanger, É., Ding, S., Hamadama, O. G., Ngoume, Y. F., Tauzin, A., et al. (2025) · Virology · doi:10.1016/j.virol.2025.110467 · Cited by 2
Zhang, C., Wang, T., Dong, C., Dai, D., Zhou, L., Li, Z., & Xu, S. (2025) · Journal of Medical Internet Research · doi:10.2196/54543 · Cited by 2
Park, Y.-J., Jankowski, W., Hurst, N. C., Fry, J. W., Schwabe, N. F., Tan, L. C. C., & Sauna, Z. E. (2025) · The AAPS Journal · doi:10.1208/s12248-025-01043-8 · Cited by 3
Hailu, G., Legesse, M., Mulu, A., Medhin, G., Tsegaye, M. M., Alemayehu, D. H., Ayele, A., Weldemariam, A. G., Tayachew, A., Aguine, A., et al. (2025) · Genes · doi:10.3390/genes16030351 · Cited by 2
Gustani‐Buss, E., Buss, C. E., de Biagi, C. A. O., de Oliveira, I. M., Peronni, K. C., Vitiello, G. A. F., Fermino, B. L., Ivanski, F., Chão, B. M. P., Tuon, F. F., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70318 · Cited by 2
COVID-19 vaccination induces cross-neutralisation of sarbecoviruses related to SARS-CoV-2
West, G. E., Morse, R. B., Sievers, B. L., Abdullahi, A., Kamelian, K., Cheng, M. T. K., Bradley, J. R., Baker, S., Graves, B., Stark, H., et al. (2026) · npj Vaccines · doi:10.1038/s41541-026-01469-x · Cited by 2
Computational Design and Evaluation of Peptides to Target SARS-CoV-2 Spike–ACE2 Interaction
Almabhouh, S., Cecon, E., Basubas, F., Molina-Fernández, R., Stępniewski, T. M., Selent, J., Jockers, R., Rahmeh, A. A., Oliva, B., & Fernández‐Fuentes, N. (2025) · Molecules · doi:10.3390/molecules30081750 · Cited by 2
Chen, F., Jia, R., Wang, Q., Li, M., Su, H., Lan, M., & Zheng, L. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1528189 · Cited by 3
Saifi, E., Faita, F., Nardin, M., Orizio, P., Arrigoni, A., Roccon, B. M., Accordini, B., Cecchinel, S., Poisa, P., Pelizzari, G., et al. (2025) · Clinics And Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102606 · Cited by 2
Cerdán, L., Silva, K. S. D., Rodríguez-Martín, D., Pérez, P., Noriega, M. A., Martín, A. E., Gutiérrez‐Adán, A., Margolles, Y., Sánchez, J. A. C., Martín-Acebes, M. A., et al. (2025) · mAbs · doi:10.1080/19420862.2025.2499595 · Cited by 2
Yu, L., Lin, S., Shen, Z. M., & Zhang, J. (2025) · Health Care Management Science · doi:10.1007/s10729-025-09703-z · Cited by 2
Omer, E. A., Abdelfatah, S., Shahhamzehei, N., Guthart, A., Sutter, K., Sperber, H. S., Schwarzer, R., & Efferth, T. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118246 · Cited by 2
Csollarova, K., Koletzko, L., Thi, T. G. L., Wratil, P. R., Zhelyazkova, A., Breiteneicher, S., Stern, M., Lupoli, G., Schwerd, T., Choukèr, A., et al. (2025) · Vaccines · doi:10.3390/vaccines13070673 · Cited by 2
Liang, Z., Zhang, H., Xu, L., Li, N., Yin, Z., Sun, Y., Shen, N., Guo, Z., Wang, Y., Xue, L., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06756-0 · Cited by 2
Wang, H., Zhang, Z., Gan, M., Cui, Z., Wu, B., Feng, S., Xu, J., Cao, J., Wen, Y., Wang, Z., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70487 · Cited by 2
Genomic epidemiology of SARS-CoV-2 in Norfolk, UK, March 2020–December 2022
Hayles, E. H., Page, A. J., Kingsley, R. A., Guitián, J., & Langridge, G. C. (2025) · Microbial Genomics · doi:10.1099/mgen.0.001435 · Cited by 2
Silva, M. D. O., Daher, I. P., Ibrahim, C. H. O., de Souza, E. E., Postól, E., de Alencar, R. E., Silva, G. A. D. S., Marques, R. F., Adami, F. L., Schuch, V., et al. (2025) · Virology · doi:10.1016/j.virol.2025.110629 · Cited by 2
Eco-Evolutionary Constraints for the Endemicity of Rapidly Evolving Viruses
Soriano‐Paños, D. (2025) · PRX Life · doi:10.1103/43bd-hxhl · Cited by 2
García, D. D. L., Marrero‐Ponce, Y., Agüero-Chapin, G., Rodrı́guez, H., Ferri, F. J., Márquez, E., Mora, J. R., Martínez-Rios, F., & Pérez‐Castillo, Y. (2025) · Computers · doi:10.3390/computers14100423 · Cited by 3
Lohachova, K. O., Sviatenko, A. S., Kyrychenko, A. V., & Kalugin, O. N. (2024) · Kharkov University Bulletin Chemical Series · doi:10.26565/2220-637x-2024-43-02 · Cited by 3
Kekana, D., Ntozini, B., Hisner, R., Yousif, M., Ntuli, P., Ndlovu, N., McCarthy, K., Mnguni, A., Mahlangu, B., Nzimande, A., et al. (2025) · Virus Evolution · doi:10.1093/ve/veaf083 · Cited by 2
Nanoparticles and Other Nanostructures and the Control of Pathogens: From Bench to Vaccines
Boudier, A., & Faou, A. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109063 · Cited by 3
Dynamic Evolution of SARS-CoV-2 in a Patient on Chemotherapy
Huang, W., Yin, C., Briley, K. P., Dalzell, W. A. B., & Fallon, J. T. (2023) · Viruses · doi:10.3390/v15081759 · Cited by 3
Natural Products: A Potential New Hope to Defeat Post-acute Sequelae of COVID-19
Zhao, S., Abdurehim, A., Yuan, Y., Tan, Y., Li, C., Zhang, Y., Li, Y., Sun, X., & Xie, J. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230829164156 · Cited by 2
Ramasamy, R. (2023) · International Journal of Microbiology Research · doi:10.4103/ijmr.ijmr_2591_22 · Cited by 2
Tracking SARS-CoV-2 variants during the 2023 flu season and beyond in Lebanon
Kodsi, I. A., Rayes, D. E., Koweyes, J., Khoury, C. A., Rahy, K., Thoumi, S., Chamoun, M., Haddad, H., Mokhbat, J., & Tokajian, S. T. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199289 · Cited by 4
Sensecor: A framework for COVID-19 variants severity classification and symptoms detection
Balaji, T., Bablani, A., Sreeja, S. R., & Misra, H. (2023) · Evolving Systems · doi:10.1007/s12530-023-09558-1 · Cited by 2
Priyadarsinee, L., Jamir, E., Nagamani, S., Mahanta, H. J., Kumar, N., John, L., Sarma, H., Kumar, A., Gaur, A. S., Sahoo, R., et al. (2024) · Gigabyte · doi:10.46471/gigabyte.114 · Cited by 2
Shi, Y., Ma, Y., Zheng, Z., Qin, Y., Du, Z., & Liu, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28627 · Cited by 2
Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins
Afridonova, Z. E., Топтыгина, А. П., & Mikhaylov, I. S. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924050080 · Cited by 2
Genomic Analysis and Tracking of SARS‐CoV‐2 Variants in Gwangju, South Korea, From 2020 to 2022
Lee, Y., Lee, K. H., Lee, H., Park, J. W., Cho, S., Park, J., Mun, J., Park, S., Lee, C., Lee, J. M., et al. (2024) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13350 · Cited by 2
Fozard, J., Thomson, E. C., & Illingworth, C. J. R. (2024) · Journal of The Royal Society Interface · doi:10.1098/rsif.2024.0168 · Cited by 2
Evolutionary rescue effect disappears under more realistic assumptionsPreprint
Hinsch, M., Robertson, D. L., & Silverman, E. (2023) · medRxiv · doi:10.1101/2023.05.19.23290032 · Cited by 2
Crykey: Rapid Identification of SARS-CoV-2 Cryptic Mutations in WastewaterPreprint
Liu, Y., Sapoval, N., Gallego‐García, P., Tomás, L., Posada, D., Treangen, T. J., & Stadler, L. B. (2023) · medRxiv · doi:10.1101/2023.06.16.23291524 · Cited by 2
Inferring Viral Transmission Pathways from Within-Host VariationPreprint
Specht, I., Petros, B. A., Moreno, G. K., Brock-Fisher, T. M., Krasilnikova, L. A., Schifferli, M., Yang, K. Y., Cronan, P., Glennon, O., Schaffner, S. F., et al. (2023) · medRxiv · doi:10.1101/2023.10.14.23297039 · Cited by 2
Efficient overexpression and purification of SARS-CoV-2 Nucleocapsid proteins in Escherichia coliPreprint
Brudenell, E. L., Pohare, M. B., Zafred, D., Phipps, J., Hornsby, H. R., Darby, J. F., Dai, J., Liggett, E., Cain, K. M., Barran, P. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.08.574531 · Cited by 2
SARS-CoV-2 Omicron Envelope T9I adaptation confers resistance to autophagyPreprint
Klute, S., Nchioua, R., Cordsmeier, A., Vishwakarma, J., Koepke, L., Alshammary, H., Jung, C., Hirschenberger, M., Hoenigsperger, H., Fischer, J.-R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.23.590789 · Cited by 2
Singh, V., Bhutkar, M., Choudhary, S., Nehul, S., Kumar, R., Singla, J., Kumar, P., & Tomar, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.13.593833 · Cited by 2
Global siRNA Screen Reveals Critical Human Host Factors of SARS-CoV-2 Multicycle ReplicationPreprint
Yin, X., Yuan, P., Yuan, S., Pache, L., Churas, C., Weston, S. M., Riva, L., Simons, L. M., Cisneros, W. J., Clausen, T. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.10.602835 · Cited by 2
Yang, S., Luo, X., Luo, J., Jian, F., & Cao, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.17.683094 · Cited by 2
Pociūtė, A., Kriaučiūnaitė, K., Kaušylė, A., Zablockienė, B., Alčauskas, T., Jelinskaitė, A., Rudėnaitė, A., Jančorienė, L., Ročka, S., Verkhratsky, A., et al. (2024) · Function · doi:10.1093/function/zqae002 · Cited by 2
Ye, Q., Wang, H., Xu, F., Zhang, S., Zhang, S., Yang, Z., & Zhang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094662 · Cited by 1
Estimating the effective reproduction number of COVID-19 via the chain ladder method
Lin, X., Matsunaka, Y., & Shiraishi, H. (2024) · Japanese Journal of Statistics and Data Science · doi:10.1007/s42081-024-00252-3 · Cited by 1
Morotti, D., Tabano, S. M., Gaudioso, G., Radaelli, T., Croci, G. A., Bianchi, N., Ghirardi, G., Gianatti, A., Patanè, L., de Chaurand, V. P., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168825 · Cited by 1
Timeline of the pandemic: epidemiology, global spread, variants and waves
Liu, Y.-X., Luo, J.-Y., Liu, R., Li, Y., & Guan, W. (2024) · European Respiratory Society eBooks · doi:10.1183/2312508x.10018823 · Cited by 1
Thrombotic Consequences of COVID ‐19 Infection on Microsurgical Reconstruction
Han, S. H., Ockerman, K. M., Kirchmier, M., Mardourian, M., Bryan, J. L., Cox, E., Chim, H., Spiguel, L. E., Momeni, A., & Sorice-Virk, S. C. (2024) · Microsurgery · doi:10.1002/micr.31219 · Cited by 1
Laref, N., Belkheir, K., Belazreg, M., & Hireche, A. (2024) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-024-00531-8 · Cited by 1
Lin, Y., Cho, S., Hsieh, Y.-L., Chuang, Y., Hsu, C.-E., Liu, Y.-C., Sung, C.-C., Huang, Y.-H., Ku, W. L., Hsieh, M., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1402194 · Cited by 1
Study of Potential Blocking Peptides Targeting the SARS-CoV-2 RBD/hACE2 Interaction
Villada-Troncoso, S. M., Romero, J. A. A., Rivera, V. H., Pedraza‐Escalona, M., Pérez‐Tapia, S. M., Espejo-Mojica, A. J., & Alméciga-Díaz, C. J. (2024) · Pharmaceuticals · doi:10.3390/ph17091240 · Cited by 1
Zawawi, Z. M., Kalyanasundram, J., Zain, R. M., Ripen, A. M., Basri, D., & Yap, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910541 · Cited by 1
Zhao, N., He, M. Y., Wang, H., Zhu, L., Wang, N., Yong, W. S., Fan, H., Ding, S., Ma, T., Zhang, Z., et al. (2024) · Virus Evolution · doi:10.1093/ve/veae085 · Cited by 1
The 3rd anniversary of Frontiers in Virology: aiming to consolidate the virus research
Adachi, A., Koma, T., & Nomaguchi, M. (2024) · Frontiers in Virology · doi:10.3389/fviro.2024.1505809 · Cited by 1
Cui, J., Hu, A., Xiong, X.-H., Wang, Q., Chen, Z., Chen, Z., Lu, Y., Xia, X., Chen, H., & Liu, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111514 · Cited by 1
Chrysostomou, A. C., The COMESSAR Network, & Kostrikis, L. G. (2024) · Viruses · doi:10.3390/v16111686 · Cited by 1
Muehleman, D., Gruner, B., Hogan, V., Fanning, P., Garrett, C., Meyer, J., Lanter, K., Purves, S., DeMarcus, L. S., Thervil, J. W., et al. (2024) · Emerging infectious diseases · doi:10.3201/eid3014.240231 · Cited by 1
Li, Y., Lin, Y., Yi, Y., Zhu, N., Cui, X., & Li, X. (2024) · Vaccines · doi:10.3390/vaccines12121365 · Cited by 1
Komorowski, A. S., Mbuagbaw, L. C. E., Jeyanathan, M., Afkhami, S., Swinton, M. E., D’Agostino, M. R., Howie, K. J., Medina, M. F. C., Gauvreau, G. M., Brister, D. L., et al. (2025) · ERJ Open Research · doi:10.1183/23120541.00758-2024 · Cited by 1
Jin, S. M., Cho, J. H., Seong, Y., Chathuranga, W. A. G., Gwak, Y., Noh, Y., Lee, M., Oh, S., Choi, J., Lee, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202412116 · Cited by 1
Protective potential of structural proteins of the SARS-CoV-2 virus in protecting against COVID-19
Dolzhikova, I. V., Grousova, D. M., Zorkov, I. D., Iliukhina, A. A., Витальевна, К. А., Zubkova, O. V., Popova, O. D., Ozharovskaia, T. A., Игоревич, З. Д., Savina, D. M., et al. (2024) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-577 · Cited by 1
Feng, S., Bibi, S., Aley, P. K., Cappuccini, F., Clutterbuck, E., Conlin, K., Ebrahimi, N., Eordogh, A., Faust, S. N., Felle, S., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106423 · Cited by 1
Activation of Evolutionarily Young Endogenous Retroviruses Is Implicated in COVID‐19 Immunopathology
Yoshida, R., & Ohtani, H. (2025) · Genes to Cells · doi:10.1111/gtc.13194 · Cited by 1
Virology Applications to the COVID-19 Pandemic
Kostaki, E. G. (2025) · Life · doi:10.3390/life15020247 · Cited by 1
Trempelis, K. P., Kosmeri, C., Kalavas, P., Ladomenou, F., Siomou, E. C., & Makis, A. C. (2025) · Diseases · doi:10.3390/diseases13020048 · Cited by 1
Comparison of Airborne SARS‐CoV‐2 Omicron and Pre‐Delta Variants Around Infected Patients
Fraenkel, C., Thuresson, S., Medstrand, P., Alsved, M., & Löndahl, J. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70258 · Cited by 1
Lee, M., Kwon, J., Kim, H. B., Woo, S., & Oh, S. S. (2025) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2025.117311 · Cited by 1
Lin, E. P.-Y., Hsu, C., Mishra, S., Griffiths, E. A., Segal, B. H., Hwang, C., Singh, S. R. K., Balanchivadze, N., Jani, C., Mariano, M. G., et al. (2025) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2025.101038 · Cited by 1
Out-of-hospital cardiac arrest survival in Black & Hispanic communities since the COVID-19 pandemic
Hall, E. J., Li, Q., Chan, P. S., McNally, B., Al‐Araji, R., de Lemos, J. A., Uzendu, A. I., & Girotra, S. R. (2025) · Resuscitation · doi:10.1016/j.resuscitation.2025.110579 · Cited by 1
Roberts, A. I., Santostefano, C. M., Chen, Z., McGarry, B. E., White, E. M., Resnik, L. J., Geng, F., Grabowski, D. C., & Rahman, M. (2025) · Health Affairs Scholar · doi:10.1093/haschl/qxaf056 · Cited by 1
Sukik, L., Chemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., et al. (2025) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2024-002718 · Cited by 1
Placental lesions induced by Omicron SARS-CoV-2 in a pregnant woman treated with anti-CD20
Dubucs, C., Dupuis, N., Jourdes, A., Delobel, P., Auzet, C., Acker, N. V., Pasquier, C., & Aziza, J. (2025) · Placenta · doi:10.1016/j.placenta.2025.03.015 · Cited by 2
Aljabali, A. A. A., Obeid, M. A., Gammoh, O. S., El‐Tanani, M., & Tambuwala, M. M. (2025) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2025.01.005 · Cited by 2
Li, Y., Friedemann, T., Pan, J., Li, X., Wang, F., Lin, Y., Zhu, Q., Schröder, S., Liu, Q., & Lu, H. (2025) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2025.04.005 · Cited by 1
Li, G., Liu, R., Chen, Y., Liang, H., Liang, Y., Li, X., Ke, Y., Lin, B., Zhong, J., Guo, X., et al. (2025) · Molecular Phylogenetics and Evolution · doi:10.1016/j.ympev.2025.108369 · Cited by 1
Wratil, P. R., Schmacke, N. A., Karakoc, B., Dächert, C., Apak, E., Krenn, F., Bjedov, S., Badell, I., Pflantz, T., Lübke, A., et al. (2025) · Infection · doi:10.1007/s15010-025-02526-8 · Cited by 1
Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxis
Nielsen, S. S. F., Rothemejer, F. H., Andreas, M., Pedersen, M. L., Traberg‐Nyborg, L., Iversen, E. F., Juhl, A. K., Søgaard, O. S., Schleimann, M. H., & Tolstrup, M. (2025) · Virology · doi:10.1016/j.virol.2025.110573 · Cited by 1
Dai, Z., Liu, X., Jing, S., Wang, H., Huang, Y., Fu, J., Wu, Y., Zhang, L., Han, B., & Su, X. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06886-1 · Cited by 2
López, D., Rivera-Franco, N., Aristizábal, E., Solarte, M., Castillo, A., Pardo, C. A., & Parra, B. (2025) · Viruses · doi:10.3390/v17060800 · Cited by 1
Variant evolution graph: Can we infer how SARS-CoV-2 variants are evolving?
Das, B., & Heath, L. S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323970 · Cited by 1
Li, Y., Li, Y., Xu, L. L., Liu, F., Dai, W., Chen, M., Ji, J., Jin, Q., & Wang, K. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202501446 · Cited by 1
The adverse effects of large-scale vaccination on highly transmissible epidemics
Zhou, Y., Liu, Y., Zhang, X., & Zhou, J. (2025) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2025.130722 · Cited by 1
Lee, K., Demirev, A. V., Lee, S., Cho, S., Kim, H., Cho, J., Yang, J., Kim, K.-C., Lee, J., Shin, W., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1619546 · Cited by 1
Sánchez‐Simarro, Á., Carretero, D., Grau, B., Martínez‐Pérez, M., Albert, E., Giménez, E., Colomer, E., Panizo, N., Hernani, R., Espert, A. H., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70463 · Cited by 1
Maze, M. J., Rodgers, H., Williman, J. A., Anstey, R., Best, E., Bhally, H. S., Bryce, A. N., Chang, C. L., Chen, K., Dummer, J. F., et al. (2025) · Internal Medicine Journal · doi:10.1111/imj.70114 · Cited by 1
de Campos, C. F., Ibañez‐Lligoña, M., Colomer‐Castell, S., Gregori, J., García‐Cehic, D., Andrés, C., Piñana, M., Gónzalez‐Sánchez, A., Rando‐Segura, A., Esperalba, J., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70476 · Cited by 1
Coats, A., Wang, Y. R., & Koelle, K. (2025) · Virus Evolution · doi:10.1093/ve/veaf054 · Cited by 2
Metadata
- Authors
- Markov, P. V., Ghafari, M., Beer, M., Lythgoe, K., Simmonds, P., Stilianakis, N. I., & Katzourakis, A.
- Affiliations
- University of London (GB)
- University of Oxford (GB)
- Friedrich-Loeffler-Institut (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Corresponding author
- Markov, Peter V.
- Katzourakis, Aris
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2023-04-05
- Volume
- 21
- Issue
- 6
- Pages
- 361-379
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W4362609000
- Semantic Scholar
- b6c3324e790174aac7a7b28fcfe0bc22f5461418
- Cited by
- 1,179
- References
- 225
- Citations by year
- 2026: 204 · 2025: 390 · 2024: 441 · 2023: 130
- FWCI
- 55.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- OpenAgrar (submittedVersion)
- Funders
- Wellcome Trust (107652/Z/15/Z)
- H2020 European Research Council (101001623)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- SARS-CoV-2, viral evolution, genetic variation, variants of concern, antigenic evolution, immune evasion, reinfection, recombination, chronic infection, reservoir hosts, transmissibility, disease severity, COVID-19 pandemic, evolutionary trajectories
- MeSH terms
- COVID-19, SARS-CoV-2, Animals, Genomics, Immune Evasion, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
